FDA De Novo Submission Services
Cert3Global provides expert FDA De Novo Submission services to help manufacturers bring novel medical devices to the U.S. market through the FDA’s De Novo pathway. Our regulatory team supports manufacturers with regulatory strategy, submission planning, technical documentation, and FDA communication to help streamline the review process and improve submission readiness.
Whether you are developing an innovative technology or introducing a first-of-its-kind medical device, our De Novo consulting services provide the guidance needed to navigate this specialized regulatory pathway with confidence.
Expert FDA De Novo Submission Support for Novel Medical Devices
The FDA De Novo pathway is designed for novel medical devices that do not have a legally marketed predicate device but can demonstrate reasonable assurance of safety and effectiveness. It provides an alternative classification process for low-to-moderate risk devices that would otherwise automatically fall into Class III due to the absence of a predicate device.
Preparing a successful De Novo request requires careful planning, comprehensive documentation, and a clear regulatory strategy. Manufacturers must demonstrate that the device’s benefits outweigh its risks and provide sufficient information to support FDA’s classification decision.
Cert3Global provides practical and structured FDA De Novo Submission services that help manufacturers understand regulatory expectations, develop strong submission strategies, and prepare complete documentation packages. Our goal is to simplify the process and help manufacturers achieve a more efficient path to U.S. market entry.
What is an FDA De Novo Submission?
An FDA De Novo Submission is a regulatory pathway established for novel medical devices that do not have a substantially equivalent predicate device already marketed in the United States.
The De Novo process allows FDA to classify these devices into Class I or Class II when general controls or a combination of general and special controls can reasonably assure their safety and effectiveness.
Unlike the traditional 510(k) pathway, which relies on substantial equivalence to a predicate device, the De Novo process requires manufacturers to provide sufficient evidence demonstrating the device’s safety profile, intended use, risk mitigation measures, and performance characteristics.
Once a De Novo request is granted, the device receives a new classification regulation and may subsequently serve as a predicate for future 510(k) submissions involving similar technologies.
Why is FDA De Novo Submission Important?
Key Benefits:
- Obtain market authorization for novel medical devices
- Establish a new device classification regulation
- Avoid unnecessary PMA requirements
- Create future regulatory opportunities for similar technologies
- Introduce innovative healthcare solutions to the U.S. market more efficiently
FDA De Novo Submission Services You Can Rely On
Regulatory Strategy & Pathway Assessment
We evaluate your product, intended use, and technology to determine whether the De Novo pathway is the most appropriate regulatory route.
Device Classification Support
Our experts assist in developing classification strategies and identifying the applicable controls needed to demonstrate safety and effectiveness.
Documentation Preparation
We support the preparation and organization of submission documentation, ensuring all required information is clearly presented and submission-ready.
Risk Assessment & Mitigation Support
We help manufacturers identify potential risks and document mitigation measures that support the device's benefit-risk profile.
FDA Communication Support
We assist with regulatory correspondence and help manufacturers prepare responses to FDA questions throughout the review process.
Submission Readiness Review
We conduct structured reviews to identify gaps, improve documentation quality, and strengthen overall submission readiness.
FDA De Novo Submission Process
- Regulatory pathway assessment
- Device description and intended use definition
- Risk analysis and mitigation planning
- Preparation of supporting documentation and evidence
- Submission of the De Novo request to FDA
- FDA review and requests for additional information, if applicable
- Final classification decision and authorization
Who Needs FDA De Novo Submission Services?
- Manufacturers of novel medical devices
- Startups introducing first-of-its-kind technologies
- Companies developing emerging digital health solutions
- Manufacturers whose products are not eligible for the 510(k) pathway
- Organizations seeking a structured route to U.S. market authorization
Why Choose Cert3Global?
- End-to-end De Novo consulting support
- Regulatory strategy and pathway assessment
- Documentation and submission preparation assistance
- Risk assessment and review support
- FDA communication guidance
- Practical solutions tailored to novel medical technologies
Start Your FDA De Novo Submission Journey!
Bringing an innovative medical device to the U.S. market requires a clear regulatory strategy and thorough preparation. Cert3Global’s FDA De Novo Submission services help manufacturers navigate every stage of the process with practical guidance and regulatory expertise.
Whether you are developing a breakthrough technology or seeking an alternative to traditional pathways, our team is ready to support your journey toward FDA authorization.